二代测序在胰腺病变细胞学诊断中的作用
本文综述二代测序在胰腺病变术前诊断中的应用。通过检索2000至2017年PubMed文献,发现KRAS仍是术前单基因检测研究最广泛的基因,二代测序可从有限DNA中可靠分析多基因标志物,多基因panel分析已成为胰腺癌患者管理和术前风险分层的极具吸引力的选择。
要点
- KRAS仍是胰腺病变术前单基因检测研究最广泛的基因。
- 二代测序可从有限DNA中可靠分析多个基因标志物。
- 多基因panel分析对胰腺癌术前风险分层有重要价值。
核心结论
- 二代测序可从有限DNA中可靠分析多个基因标志物,多基因panel分析对胰腺癌术前风险分层极具吸引力。
研究设计与样本
- 综述性研究,检索PubMed 2000至2017年文献,检索词包括next-generation sequencing、pancreas、pancreatic lesions、pancreatic tumors和EUS-FNA。
主要发现
- KRAS仍是术前单基因检测研究最广泛的基因。
- 二代测序技术可从有限DNA量中可靠分析多个基因标志物。
- 多基因panel分析已成为胰腺癌患者管理和术前风险分层的极具吸引力的选择。
临床怎么用
- 可将二代测序多基因panel分析用于胰腺病变术前诊断和风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: - Integration of the analysis of genetic markers with endoscopic ultrasound-guided fine-needle aspiration and cytologic evaluation has increased the accuracy of the preoperative diagnosis of pancreatic lesions. The application of high-throughput gene panel analysis using next-generation sequencing platforms is now offering a great opportunity for further improvements. OBJECTIVE: - To review the application of next-generation sequencing to the preoperative diagnosis of pancreatic lesions. DATA SOURCES: - For data acquisition, a PubMed search using the terms next-generation sequencing, pancreas, pancreatic lesions, pancreatic tumors, and EUS-FNA was performed covering the years 2000-2017. CONCLUSIONS: - KRAS remains the gene most widely studied for preoperative single-gene tests. Next-generation sequencing reliably allows analysis of multiple gene markers starting from limited amounts of DNA. The study of multigene panels has become a very attractive option for the management and preoperative risk stratification of patients with pancreatic cancer.
引用
- de Biase D, Visani M, Acquaviva G, et al. The Role of Next-Generation Sequencing in the Cytologic Diagnosis of Pancreatic Lesions. Arch Pathol Lab Med. 2018. PMID: 29565213. doi:10.5858/arpa.2017-0215-RA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。